Neurocognitive assessment following whole brain radiation therapy and radiosurgery for patients with cerebral metastases

Journal of Neurology, Neurosurgery and Psychiatry

Volumn 84, Issue 12, 2013, Pages 1384-1391

  McDuff, Susan G R ^a   Taich, Zachary J ^a   Lawson, Joshua D ^b   Sanghvi, Parag ^b   Wong, Eric T ^c   Barker II, Fred G ^d   Hochberg, Fred H ^d   Loeffler, Jay S ^d   Warnke, Peter C ^e   Murphy, Kevin T ^b   Mundt, Arno J ^b   Carter, Bob S ^a,f   McDonald, Carrie R ^a,g   Chen, Clark C ^a,f  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^c BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^d MASSACHUSETTS GENERAL HOSPITAL   (United States)

^e UNIVERSITY OF CHICAGO MEDICAL CENTER   (United States)

^f UNIVERSITY OF CALIFORNIA   (United States)

^g UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN FUNCTION; BRAIN METASTASIS; BRAIN RADIATION; BRAIN SIZE; CANCER RADIOTHERAPY; CANCER SURGERY; CANCER SURVIVAL; CELL POPULATION; COGNITION; DEGRADATION; DENTATE NUCLEUS; HIPPOCAMPUS; HUMAN; INTELLIGENCE QUOTIENT; MINI MENTAL STATE EXAMINATION; NERVOUS SYSTEM DEVELOPMENT; NEUROLOGIC EXAMINATION; OLIGODENDROGLIA; PRIORITY JOURNAL; PSYCHOMOTOR PERFORMANCE; QUALITY OF LIFE; RADIATION DOSE; REOXYGENATION; REVIEW; STEREOTACTIC RADIOSURGERY; SURVIVAL RATE; TEST RETEST RELIABILITY; TUMOR VOLUME; VERBAL MEMORY;

EID: 84888054283     PISSN: 00223050     EISSN: 1468330X     Source Type: Journal    
DOI: 10.1136/jnnp-2013-305166     Document Type: Review

References (87)

1. Walker AE, Robins M, Weinfeld FD. Epidemiology of Brain-Tumors - the National Survey of Intracranial Neoplasms. Neurology 1985;35:219-26.
2. Simpson JR, Mendenhall WM, Schupak KD, et al. Follow-up and retreatment of brain metastasis. American College of Radiology. ACR Appropriateness Criteria. Radiology 2000;215(Suppl):1129-35.
3. Nayak L, Lee EQ, Wen PY. Epidemiology of brain metastases. Curr Oncol Rep 2012;14:48-54.
4. Nussbaum ES, Djalilian HR, Cho KH, et al. Brain metastases. Histology, multiplicity, surgery, and survival. Cancer 1996;78:1781-8.
5. Schneider EL, Guralnik JM. The aging of America. Impact on health care costs. JAMA 1990;263:2335-40.
6. Langer CJ, Mehta MP. Current management of brain metastases, with a focus on systemic options. J Clin Oncol 2005;23:6207-19.
7. Neuwelt E, Abbott NJ, Abrey L, et al. Strategies to advance translational research into brain barriers. Lancet Neurol 2008;7:84-96.
8. Pegram M, Liao J. Trastuzumab treatment in multiple lines: current data and future directions. Clin Breast Cancer 2012;12:10-18.
9. Burstein HJ, Lieberman G, Slamon DJ, et al. Isolated central nervous system metastases in patients with HER2-overexpressing advanced breast cancer treated with first-line trastuzumab-based therapy. Ann Oncol 2005;16:1772-7.
10. Sperduto PW, Chao ST, Sneed PK, et al. Diagnosis-specific prognostic factors, indexes, and treatment outcomes for patients with newly diagnosed brain metastases: a multi-institutional analysis of 4,259 patients. Int J Radiat Oncol Biol Phys 2010;77:655-61.
11. Hall WA, Djalilian HR, Nussbaum ES, et al. Long-term survival with metastatic cancer to the brain. Med Oncol 2000;17:279-86.
12. Patchell RA. The management of brain metastases. Cancer Treat Rev 2003;29:533-40.
13. Altundag K, Bondy ML, Mirza NQ, et al. Clinicopathologic characteristics and prognostic factors in 420 metastatic breast cancer patients with central nervous system metastasis. Cancer 2007;110:2640-7.
14. Nieder C, Nestle U, Motaref B, et al. Prognostic factors in brain metastases: should patients be selected for aggressive treatment according to recursive partitioning analysis (RPA) classes? Int J Radiat Oncol Biol Phys 2000;46:297-302.
15. Sperduto PW, Kased N, Roberge D, et al. Summary report on the graded prognostic assessment: an accurate and facile diagnosis-specific tool to estimate survival for patients with brain metastases. J Clin Oncol 2012;30:419-25.
16. Gaspar L, Scott C, Rotman M, et al. Recursive partitioning analysis (RPA) of prognostic factors in three Radiation Therapy Oncology Group (RTOG) brain metastases trials. Int J Radiat Oncol Biol Phys 1997;37:745-51.
17. Nieder C, Spanne O, Mehta MP, et al. Presentation, patterns of care, and survival in patients with brain metastases: what has changed in the last 20 years? Cancer 2011;117:2505-12.
18. Gehring K, Sitskoorn MM, Aaronson NK, et al. Interventions for cognitive deficits in adults with brain tumours. Lancet Neurol 2008;7:548-60.
19. Eichler AF, Loeffler JS. Multidisciplinary management of brain metastases. Oncologist 2007;12:884-98.
20. Bernier J, Hall EJ, Giaccia A. Radiation oncology: a century of achievements. Nat Rev Cancer 2004;4:737-47.
21. Posner JB. Management of brain metastases. Rev Neurol (Paris) 1992;148:477-87.
22. Patchell RA, Tibbs PA, Regine WF, et al. Postoperative radiotherapy in the treatment of single metastases to the brain: a randomized trial. JAMA 1998;280:1485-9.
23. Andrews DW, Scott CB, Sperduto PW, et al. Whole brain radiation therapy with or without stereotactic radiosurgery boost for patients with one to three brain metastases: phase III results of the RTOG 9508 randomised trial. Lancet 2004;363:1665-72.
24. Vermeulen SS. Whole brain radiotherapy in the treatment of metastatic brain tumors. Semin Surg Oncol 1998;14:64-9.
25. Peacock KH, Lesser GJ. Current therapeutic approaches in patients with brain metastases. Curr Treat Options Oncol 2006;7:479-89.
26. Aoyama H, Shirato H, Tago M, et al. Stereotactic radiosurgery plus whole-brain radiation therapy vs stereotactic radiosurgery alone for treatment of brain metastases: a randomized controlled trial. JAMA 2006;295:2483-91.
27. Chang EL, Wefel JS, Hess KR, et al. Neurocognition in patients with brain metastases treated with radiosurgery or radiosurgery plus whole-brain irradiation: a randomised controlled trial. Lancet Oncol 2009;10:1037-44.
28. Tsao M, Xu W, Sahgal A. A meta-analysis evaluating stereotactic radiosurgery, whole-brain radiotherapy, or both for patients presenting with a limited number of brain metastases. Cancer 2012;118:2486-93.
29. Shors TJ, Miesegaes G, Beylin A, et al. Neurogenesis in the adult is involved in the formation of trace memories. Nature 2001;410:372-6.
30. Monje ML, Palmer T. Radiation injury and neurogenesis. Curr Opin Neurol 2003;16:129-34.
31. Grill J, Renaux VK, Bulteau C, et al. Long-term intellectual outcome in children with posterior fossa tumors according to radiation doses and volumes. Int J Radiat Oncol Biol Phys 1999;45:137-45.
32. Hoppe-Hirsch E, Brunet L, Laroussinie F, et al. Intellectual outcome in children with malignant tumors of the posterior fossa: influence of the field of irradiation and quality of surgery. Childs Nerv Syst 1995;11:340-5; discussion 45-6.
33. Mulhern RK, Hancock J, Fairclough D, et al. Neuropsychological status of children treated for brain tumors: a critical review and integrative analysis. Med Pediatr Oncol 1992;20:181-91.
34. Eriksson PS, Perfilieva E, Bjork-Eriksson T, et al. Neurogenesis in the adult human hippocampus. Nat Med 1998;4:1313-17.
35. Raber J, Rola R, LeFevour A, et al. Radiation-induced cognitive impairments are associated with changes in indicators of hippocampal neurogenesis. Radiat Res 2004;162:39-47.
36. Dong S, Zeng Q, Mitchell ES, et al. Curcumin enhances neurogenesis and cognition in aged rats: implications for transcriptional interactions related to growth and synaptic plasticity. PLoS One 2012;7:e31211.
37. Monje ML, Toda H, Palmer TD. Inflammatory blockade restores adult hippocampal neurogenesis. Science 2003;302:1760-5.
38. Mizumatsu S, Monje ML, Morhardt DR, et al. Extreme sensitivity of adult neurogenesis to low doses of X-irradiation. Cancer Res 2003;63:4021-7.
39. Monje ML, Vogel H, Masek M, et al. Impaired human hippocampal neurogenesis after treatment for central nervous system malignancies. Ann Neurol 2007;62:515-20.
40. Tofilon PJ, Fike JR. The radioresponse of the central nervous system: a dynamic process. Radiat Res 2000;153:357-70.
41. Akiyama K, Tanaka R, Sato M, et al. Cognitive dysfunction and histological findings in adult rats one year after whole brain irradiation. Neurol Med Chir (Tokyo) 2001;41:590-8.
42. Panagiotakos G, Alshamy G, Chan B, et al. Long-term impact of radiation on the stem cell and oligodendrocyte precursors in the brain. PLoS One 2007;2:e588.
43. Wang S, Wu EX, Qiu D, et al. Longitudinal diffusion tensor magnetic resonance imaging study of radiation-induced white matter damage in a rat model. Cancer Res 2009;69:1190-8.
44. Correa DD. Neurocognitive function in brain tumors. Curr Neurol Neurosci Rep 2010;10:232-9.
45. Meyers CA, Geara F, Wong PF, et al. Neurocognitive effects of therapeutic irradiation for base of skull tumors. Int J Radiat Oncol Biol Phys 2000;46:51-5.
46. Tombaugh TN, McIntyre NJ. The mini-mental state examination: a comprehensive review. J Am Geriatr Soc 1992;40:922-35.
47. Murray KJ, Scott C, Zachariah B, et al. Importance of the mini-mental status examination in the treatment of patients with brain metastases: a report from the Radiation Therapy Oncology Group protocol 91-04. Int J Radiat Oncol Biol Phys 2000;48:59-64.
48. Meyers CA, Rock EP, Fine HA. Refining endpoints in brain tumor clinical trials. J Neurooncol 2012;108:227-30.
49. Meyers CA, Wefel JS. The use of the mini-mental state examination to assess cognitive functioning in cancer trials: no ifs, ands, buts, or sensitivity. J Clin Oncol 2003;21:3557-8.
50. Norden AD, Wen PY, Kesari S. Brain metastases. Curr Opin Neurol 2005;18:654-61.
51. Brandt J. The hopkins verbal learning test: development of a new memory test with six equivalent forms. Clin Neuropsychol 1991;5:125-42.
52. Benedict RHB, Schretlen D, Groninger L, et al. Hopkins verbal learning test revised: normative data and analysis of inter-form and test-retest reliability. Clin Neuropsychol 1998;12:43-55.
53. Shapiro AM, Benedict RHB, Schretlen D, et al. Construct and concurrent validity of the hopkins verbal learning test - revised. Clin Neuropsychol 1999;13:348-58.
54. Vakil E, Blachstein H. Rey auditory-verbal Learning Test: structure analysis. J Clin Psychol 1993;49:883-90.
55. Bennett-Levy J. Determinants of performance on the rey-osterrieth complex figure test: an analysis, and a new technique for single-case assessment. Br J Clin Psychol 1984;23(Pt 2):109-19.
56. Bechtoldt HP, Fogel ML, Benton AL. An application of factor-analysis in neuropsychology. Psychol Record 1962;12:147-56.
57. Armitage SG. An analysis of certain psychological tests used for the evaluation of brain injury. Psychol Monogr 1946;60:1-48.
58. Arbuthnott K, Frank J. Trail making test, part B as a measure of executive control: validation using a set-switching paradigm. J Clin Exp Neuropsychol 2000;22:518-28.
59. Gronwall DM. Paced auditory serial-addition task: a measure of recovery from concussion. Percept Mot Skills 1977;44:367-73.
60. Herman MA, Tremont-Lukats I, Meyers CA, et al. Neurocognitive and functional assessment of patients with brain metastases - a pilot study. Am J Clin Oncol-Canc 2003;26:273-79.
61. Meyers CA, Brown PD. Role and relevance of neurocognitive assessment in clinical trials of patients with CNS tumors. J Clin Oncol 2006;24:1305-9.
62. Platta CS, Khuntia D, Mehta MP, et al. Current treatment strategies for brain metastasis and complications from therapeutic techniques: a review of current literature. Am J Clin Oncol 2012;33:398-407.
63. Gregor A, Cull A, Stephens RJ, et al. Prophylactic cranial irradiation is indicated following complete response to induction therapy in small cell lung cancer: results of a multicentre randomised trial. Eur J Cancer 1997;33:1752-58.
64. Grosshans DR, Meyers CA, Allen PK, et al. Neurocognitive function in patients with small cell lung cancer - effect of prophylactic cranial irradiation. Cancer 2008;112:589-95.
65. Komaki R, Meyers CA, Shin DM, et al. Evaluation of cognitive function in patients with limited small-cell lung-cancer prior to and shortly following prophylactic cranial irradiation. Int J Radiat Oncol Biol Phys 1995;33:179-82.
66. Schagen SB, Muller MJ, Boogerd W, et al. Late effects of adjuvant chemotherapy on cognitive function: a follow-up study in breast cancer patients. Ann Oncol 2002;13:1387-97.
67. Millikan RC, Player JS, Decotret AR, et al. Polymorphisms in DNA repair genes, medical exposure to ionizing radiation, and breast cancer risk. Cancer Epidemiol Biomarkers Prev 2005;14:2326-34.
68. Olshan AF, Shaw GM, Millikan RC, et al. Polymorphisms in DNA repair genes as risk factors for spina bifida and orofacial clefts. Am J Med Genet A 2005;135:268-73.
69. Smith TR, Levine EA, Perrier ND, et al. DNA-repair genetic polymorphisms and breast cancer risk. Cancer Epidemiol Biomarkers Prev 2003;12(11 Pt 1):1200-4.
70. Smith TR, Miller MS, Lohman K, et al. Polymorphisms of XRCC1 and XRCC3 genes and susceptibility to breast cancer. Cancer Lett 2003;190:183-90.
71. Wakeford R. The cancer epidemiology of radiation. Oncogene 2004;23:6404-28.
72. Catane R, Schwade JG, Yarr I, et al. Follow-up neurological evaluation in patients with small cell lung-carcinoma treated with prophylactic cranial irradiation and chemotherapy. Int J Radiat Oncol Biol Phys 1981;7:105-09.
73. Johnson BE, Becker B, Goff WB, et al. Neurologic neuropsychologic and computed cranial tomography scan abnormalities in 2-year to 10-year survivors of small-cell lung-cancer. J Clin Oncol 1985;3:1659-67.
74. Wolfson AH, Bae K, Komaki R, et al. Primary analysis of a phase Ii randomized trial radiation therapy oncology group (Rtog) 0212: impact of different total doses and schedules of prophylactic cranial irradiation on chronic neurotoxicity and quality of life for patients with limited-disease small-cell lung cancer. Int J Radiat Oncol Biol Phys 2011;81:77-84.
75. Sun A, Bae K, Gore EM, et al. Phase III trial of prophylactic cranial irradiation compared with observation in patients with locally advanced non-small-cell lung cancer: neurocognitive and quality-of-life analysis. J Clin Oncol 2011;29:279-86.
76. Arriagada R, Lechevalier T, Borie F, et al. Prophylactic cranial irradiation for patients with small-cell lung-cancer in complete remission. J Natl Cancer Inst 1995;87:183-90.
77. Le Pechoux C, Laplanche A, Faivre-Finn C, et al. Clinical neurological outcome and quality of life among patients with limited small-cell cancer treated with two different doses of prophylactic cranial irradiation in the intergroup phase III trial (PCI99-01, EORTC 22003-08004, RTOG 0212 and IFCT 99-01). Ann Oncol 2011;22:1154-63.
78. Aoyama H, Tago M, Kato N, et al. Neurocognitive function of patients with brain metastasis who received either whole brain radiotherapy plus stereotactic radiosurgery or radiosurgery alone. Int J Radiat Oncol Biol Phys 2007;68:1388-95.
79. Doyle DM, Einhorn LH. Delayed effects of whole brain radiotherapy in germ cell tumor patients with central nervous system metastases. Int J Radiat Oncol Biol Phys 2008;70:1361-4.
80. Armstrong CL, Corn BW, Ruffer JE, et al. Radiotherapeutic effects on brain function: double dissociation of memory systems. Neuropsychiatry Neuropsychol Behav Neurol 2000;13:101-11.
81. Mahmood U, Kwok Y, Regine WF, et al. Whole-brain irradiation for patients with brain metastases: still the standard of care. Lancet Oncol 11:221-2; author reply 23.
82. Hall EJ, Brenner DJ, Worgul B, et al. Genetic susceptibility to radiation. Adv Space Res 2005;35:249-53.
83. Angele S, Romestaing P, Moullan N, et al. ATM haplotypes and cellular response to DNA damage: association with breast cancer risk and clinical radiosensitivity. Cancer Res 2003;63:8717-25.
84. Correa DD, Maron L, Harder H, et al. Cognitive functions in primary central nervous system lymphoma: literature review and assessment guidelines. Ann Oncol 2007;18:1145-51.
85. Mehta MP, Shapiro WR, Phan SC, et al. Motexafin gadolinium combined with prompt whole brain radiotherapy prolongs time to neurologic progression in non-small-cell lung cancer patients with brain metastases: results of a phase III trial. Int J Radiat Oncol Biol Phys 2009;73:1069-76.
86. Gondi V, Tome WA, Mehta MP. Why avoid the hippocampus? A comprehensive review. Radiother Oncol 2010;97:370-6.
87. Ghia A, Tome WA, Thomas S, et al. Distribution of brain metastases in relation to the hippocampus: implications for neurocognitive functional preservation. Int J Radiat Oncol Biol Phys 2007;68:971-7.